As for the cholinergic transmission, it ends with the hydrolysis of the neurotransmitter acetylcholine (ACh) by either acetylcholinesterase (AChE) or butyrylcholinesterase (BuChE), two serine hydrolase enzymes which represent well‐validated targets to alleviate AD symptoms. The gene discussed is ACHE; the disease is Alzheimer disease.